DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20191944

Thyroid dysfunction in preeclampsia and related fetomaternal outcomes

Puja Banik, R. K. Praneshwari Devi, Aheibam Bidya, Akoijam Tamphasana, M. Agalya, Laiphrakpam Ranjit Singh

Abstract


Background: Changes in thyroid function in normal pregnancy are well-documented but in complicated pregnancy like preeclampsia, very little is known. Studies have shown evidences of hypothyroidism in preeclampsia necessitating thyroid function tests to be done in preeclampsia. The study was done to analyze the fetomaternal outcome of preeclampsia with coexisting thyroid dysfunction.

Methods: A cross-sectional analytical study was done over 18 months on 95 preeclamptic patients admitted at the antenatal ward and fetomaternal outcomes were analyzed according to thyroid status.

Results: Out of 95 patients with preeclampsia, 42 (44.2%) had thyroid dysfunction. Among these 42 patients, 37 (38.9%) patients had subclinical hypothyroidism, 4 (4.2%) had overt hypothyroidism and 1 (1%) had hyperthyroidism. Severe preeclampsia was seen in 64.3% of the patients with thyroid dysfunction compared with 39.6% in euthyroid patients. The mean thyroid stimulating hormone (TSH) level was significantly higher and means free thyroxine (fT4) level was significantly lower in severe preeclampsia compared with non-severe preeclampsia. Complications like abruption, intrauterine fetal death (IUD), intrauterine growth restriction (IUGR), oligohydramnios, preterm deliveries, postpartum hemorrhage (PPH), low birth weight babies, birth asphyxia in babies and subsequent neonatal intensive care unit (NICU) admissions were significantly higher (p <0.05) in the preeclampsia patients with thyroid dysfunction in comparison with euthyroid ones.

Conclusions: Hypothyroidism may be a modifiable risk factor for preeclampsia. Thyroid screening early in pregnancy may be helpful in predicting the occurrence of preeclampsia and timely thyroid hormone administration can reduce the maternal and perinatal morbidity and mortality associated with preeclampsia.


Keywords


Fetomaternal outcome, Hypothyroidism, Preeclampsia

Full Text:

PDF

References


Kumar A, Ghosh BK, Murthy NS. Maternal thyroid hormonal status in preeclampsia. Indian J Med Sci. 2005;59(2):57-63.

Carty DM, Delles C, Dominiczak AF. Preeclampsia and future maternal health. J Hypertension. 2010;28(7):1349-55.

Saxena N, Bava AK, Nandanwar Y. Maternal and perinatal outcome in severe preeclampsia and eclampsia. Int J Reprod Contracept Obstet Gynecol. 2016;5(7):2171-6.

Casey BM, Dashe JS, Wells CE, McIntire DD, Lenovo KJ, Cunningham FG. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 2005;105(2):239-45.

Sunanda K, Sravanthi P, Anupama H. Evaluation of thyroid function in pre-eclampsia. J Evolution Med Dent Sci. 2016;5(19):942-6.

Kaya E, Sahin Y, Ozkececi Z, Pasaoglu H. Relation between birth weight and thyroid function in preeclampsia eclampsia. Gynecol Obstet Invest. 1994;37:30-3.

Negro R, Mestman JH. Thyroid disease in pregnancy. Best Prac Res: Clin Endocrinol Metab. 2011;25(6):927-43.

Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21(10):1081-125.

Bankowska EM, Pawlowska A, Leibschang J. Thyroid function in pregnant women with pregnancy induced hypertension. Ginekol Pol. 2003;74(10):1044-8.

Kharb S, Sardana D, Nanda S. Correlation of thyroid functions with severity and outcome of pregnancy. Ann Med Health Sci Res. 2013;3(1):43-6.

Deshpande S, Yelikar K, Patil S, Andurkar S. Maternal thyroid hormone status in pre-eclampsia: a tertiary care hospital based study. IJRCOG. 2015;4(6):1853-7.

Khadem N, Ayatollahi H, Roodsari FV, Ayati S, Dalili E, Shahabian M, et al. Comparison of serum levels of Tri-iodothyronine (T3), Thyroxine (T4), and Thyroid-Stimulating Hormone (TSH) in preeclampsia and normal pregnancy. Iran J Reprod Med. 2012;10(1):47-52.

Singh A, Chawla S, Pandey D, JahanD, Anwar A. Fetomaternal outcome in cases of pre-eclampsia in a tertiary care referral hospital in Delhi, India: A retrospective analysis. Int J Sci Stud. 2016;4(2):100-3.

Wilson KL, Casey BM, McIntre DD, Halvorson LM, Cunningham FG. Subclinical thyroid disease and the incidence of hypertension in pregnancy. Obstet Gynecol. 2012;119(2):315-20.

Danzi S, Klein I. Thyroid hormone and blood pressure regulation. Curr Hypertens Rep. 2003;5(6):513-20.

Sheffield JS, Cunningham FG. Thyrotoxicosis and heart failure that complicate pregnancy. Am J Obstet Gynecol. 2004;190(1):211-7.

Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin End Metab. 2003;88(3):3731-7.

Alfadda A, Tamilia M. Preeclampsia-like syndrome that is associated with severe hypothyroidism in a 20-week pregnant woman. Am J Obstet Gynecol. 2004;191(5):1723-5.

Sheela SR, Dayanand CD, Sivaraj N. Evaluation of maternal thyroid hormone status and atherogenic potency in preeclampsia in Kolar district- A south west of India. Br J Med Res. 2015;10(4):1-8.

Sravani M, Ramaiah A. Study on comparison of maternal and fetal outcome in hypothyroid pregnancies with and without hypertension: a case controlled study. Asian Pac J Heal Sci. 2017;4(3):182-90.

Sardana D, Nanda S, Kharb S. Thyroid hormones in pregnancy and preeclampsia. J Turk Ger Gynecol Assoc. 2009;10(3):168-71.